Flatiron Health’s Post

In a conversation with Cancer Network®️ during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, our Co-Founder and Chief Medical Officer, Arturo LoAIza-Bonilla MD, spoke about his research in developing an AI-enabled system intended to reduce the time and resources needed to match patients to trials. He stated that it may be possible to more than double the number of patients matched to trials when integrating next-generation sequencing (#NGS) testing results into the matching process compared with manual processes. For more information, please click on the link below. 👉🏻 https://bit.ly/4co1U6n Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu #MassiveBio #AIinHealthCare #ClinicalOncology #CancerResearch

The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/enykUk_h #Oncology #PrecisionMedicine

On September 1, a new law went into effect making Texas the 11th state in the U.S. to expand access to precision medicine and biomarker testing. “Unlike traditional cancer treatments that take a more generalized approach, precision medicine leverages the genetic insights obtained from specialized testing of a patient’s tumor,” Debra Patt, M.D., Ph.D., MBA, Texas Oncology–Austin Central, shared with Austin Medical Times. “This approach empowers physicians and patients to make informed decisions, leading to improved outcomes, and reduced healthcare expenses.” Learn more about what this new law means for cancer patients throughout Texas: https://lnkd.in/gvzenJCq     #PrecisionMedicine #Oncology #HealthcareOnLinkedIn 

🎉 Exciting Update! 🎉 Our patent titled "Nanoemulsion of Cinnamon and Moringa Oleifera in the Treatment of Breast Cancer," led by Dr. Pravin Badhe and Sujit Chavan, is now officially published! This breakthrough brings us one step closer to a natural solution for breast cancer. In our pursuit of innovation, we invite potential buyers, collaborators, and industry professionals to join us. #CancerResearch, #HealthTech, #MedicalInnovation, #BreastCancerAwareness, #Biotech, #ResearchMatters, #ScienceBreakthrough, #HealthcareRevolution, #InnovationInMedicine, #CollaborationOpportunity, #MedicalScience, #BioTechNews, #PatientCare, #HealthcareIndustry, #FutureOfMedicine, #CancerTreatment, #ScienceCommunity, #ClinicalTrials, #MedTech, #GlobalHealth. #PatentPublished #HealthcareAdvancement

The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director #Oncology #PrecisionMedicine

The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/eSG4V2cr #Oncology #PrecisionMedicine

The era of precision medicine in oncology clinical development is transforming cancer treatment by tailoring therapies to individual genetic profiles, necessitating innovative trial designs and efficient clinical operations. For competitive advantages, organizations must modify their clinical development strategies to address the challenges posed by this revolution in trial design and execution. Find out more insights by Moez Benali, MD, PHd, Senior Medical Director https://lnkd.in/dnh6Hh8Q #Oncology #PrecisionMedicine

Watch our latest on-demand webinar where MEDITECH Manager of Clinical Product Management, Jennifer Ford, MBA, and GenomOncology’s Vice President of Product Innovation, James Cole, PhD, discuss how our integrated solutions are reshaping cancer care, empowering clinicians and researchers to develop impactful treatment strategies. Watch now to learn more about: 👉 The groundbreaking collaboration between MEDITECH and GenomOncology 👉 The integration of the GenomOncology Precision Oncology Platform directly into MEDITECH’s #Expanse Genomics solution 👉 How clinicians can access actionable insights and treatment options at the point of care, seamlessly merged into existing workflows Watch here: https://lnkd.in/eijGhXpJ #webinar #precisionmedicine #clinicaltrials #therapies #precisiononcology

Are your data visualizations working? To make informed treatment decisions, it is important that patients and caregivers understand the (often) complex data shown to them. But how do you present complex scientific data in a way that is easy to understand? See the results of research that was recently presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. https://ow.ly/vtC450SoAXM #ASCOAnnualMeeting #ClinicalOncology #OncologyResearch #DataVisualizations

How much have delayed or terminated #clinicaltrials cost your organization in: 1) Failing to efficiently identify patients eligible for clinical studies? 2) Opportunity cost and revenue lost for your therapeutic/drug approval?   Using #AI / #NLP and a proprietary oncology focused knowledge model to efficiently identify eligible patients, OncoLens reduces barriers between patients, physicians, and study sponsors! Used by more than 200 NCI, academic and community cancer centers for oncology treatment planning, OncoLens has close relationships with many sites and can help advance your clinical trial goals.   To learn more OncoLens’ clinical trial solutions, click here https://lnkd.in/gZm3rAd7, or contact info@oncolens.com